Literature DB >> 28262299

High Risk for Thoracotomy but not Thoracoscopic Lobectomy.

Laura L Donahoe1, Moira de Valence2, Eshetu G Atenafu3, Waël C Hanna4, Thomas K Waddell2, Andrew F Pierre2, Kazuhiro Yasufuku2, Marc de Perrot2, Marcelo Cypel2, Shaf Keshavjee2, Gail E Darling2.   

Abstract

BACKGROUND: Pulmonary lobectomy is the standard of care for resection of non-small cell lung cancer (NSCLC). Patients with compromised lung function who are considered high risk may be denied surgical treatment; thus, proper identification of those truly at high risk is critical. Video-assisted thoracic surgery (VATS) may reduce the operative risk. This study reviews our institutional experience of pulmonary lobectomy by open thoracotomy or VATS techniques in patients deemed to be high risk.
METHODS: A retrospective review of an institutional database was performed for all patients undergoing lobectomy from 2002 to 2010. Patients were grouped into high-risk (HR) and standard-risk (SR) cohorts according to the American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021 criteria.
RESULTS: From 2002 to 2010, 72 HR and 536 SR patients underwent lobectomy. Mean age was 73 years for HR and 66 years for SR (p < 0.0001). Rates of overall (p < 0.0001) and pulmonary complications (p < 0.0001) were significantly higher in the HR group. However, when HR patients were resected by VATS, there was no significant difference in overall (p = 0.1299) or pulmonary complications (p = 0.2292) compared with the SR VATS group. Moreover, overall survival was significantly lower for HR patients who had an open operation compared with VATS lobectomy or SR open (p = 0.0028).
CONCLUSIONS: VATS lobectomy offers patients who are considered to be at increased risk for open lobectomy a feasible procedure, with no difference in overall survival compared with SR patients, and decreased morbidity compared with open lobectomy. VATS lobectomy should be considered for patients who historically may not have been considered for surgical resection.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28262299     DOI: 10.1016/j.athoracsur.2016.11.076

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Physiopathology aspects of anatomical video-assisted thoracic surgery resections: current status and prospects of development.

Authors:  Majed Refai; Marco Andolfi; Armando Sabbatini
Journal:  J Vis Surg       Date:  2017-11-07

2.  Searching for an arrow hitting two targets: the time to evaluate long-term outcomes of video-assisted thoracoscopic surgery lobectomy for early-stage lung cancer.

Authors:  Tomohito Saito; Tomohiro Murakawa
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

3.  Robotic lobectomy has the greatest benefit in patients with marginal pulmonary function.

Authors:  Peter J Kneuertz; Desmond M D'Souza; Susan D Moffatt-Bruce; Robert E Merritt
Journal:  J Cardiothorac Surg       Date:  2018-06-05       Impact factor: 1.637

4.  Thoracoscopic wedge resection in single-lung patients.

Authors:  Davide Zampieri; Giuseppe Marulli; Giovanni Maria Comacchio; Marco Schiavon; Andrea Zuin; Federico Rea
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

5.  Contralateral pulmonary resection using selective bronchial blockade in postpneumonectomy patients.

Authors:  Nobutaka Kawamoto; Masashi Furukawa; Riki Okita; Masanori Okada; Masataro Hayashi; Hidetoshi Inokawa; Kazunori Okabe; Keisuke Kawata
Journal:  Thorac Cancer       Date:  2020-10-13       Impact factor: 3.500

6.  Prognostic Impact of Postoperative Complications in High-Risk Operable Non-small Cell Lung Cancer.

Authors:  Seungwook Lee; Md Roknuggaman; Jung A Son; Seungji Hyun; Joonho Jung; Seokjin Haam; Woo Sik Yu
Journal:  J Chest Surg       Date:  2022-02-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.